Neurol. praxi. 2017;18(1):58-61 | DOI: 10.36290/neu.2017.064

Pontocerebellar hypoplasia

MUDr. Tereza Svrčinová, MUDr. Vladimíra Sládková, Ph.D., MUDr. Michaela Kaiserová, Ph.D., prof. MUDr. Petr Kaňovský, CSc.
Neurologická klinika FN a LF UP Olomouc

Pontocerebellar hypoplasia is a group of heterogeneous inherited disorders. There have been reported eight different subtypes up

to now, but the most common are type 1 and 2. Usually have prenatal or early postnatal onset, typically it is manifested by severe

psychomotor retardation with hypotonia or on the other hand with spasticity. Most of the patient has microcephaly and during

the disease there are reported seizures. The diagnosis is based on genetic testing, nowadays are known several causal genes and

on neuroimaging with characteristic hypoplasia and atrophy of the cerebellum and variable pontine atrophy. We documented the

case report of two sisters with delay psychomotor development, they have severe mental retardation and severe motor impairment

with kvadruspasticity. There have been reported epileptic seizures and MR confirm hypoplasia of the cerebellum and pons.

Keywords: pontocerebellar hypoplasia, differential diagnosis of cerebellar ataxias, genetics

Published: March 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Svrčinová T, Sládková V, Kaiserová M, Kaňovský P. Pontocerebellar hypoplasia. Neurol. praxi. 2017;18(1):58-61. doi: 10.36290/neu.2017.064.
Download citation

References

  1. Anderson C, Davies JH, Lamont L, Foulds N. Early pontocerebellar hypoplasia with vanishing testes: A new syndrome? Am J Med Genet A. 2011; 155A: 667-672. Go to original source... Go to PubMed...
  2. Anttonen AK, Lehesjoki AE. Marineco-Sjogren syndrome GeneReviews(R) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2016. 2006 Nov 29.
  3. Bareš M, Apps R, Kikinis Z, Timmann D, Oz G, Ashe JJ, Loft M, Koutsikou S, Cerminara N, Bushara KO, Kašpárek T. Proceedings of the workshop on Cerebellum, Basal Ganglia and Cortical Connections Unmasked in Health and Disorder held in Brno, Czech Republic, October 17th, 2013. Cerebellum. 2015 Apr; 14(2): 142-150. doi: 10.1007/s12311-014-0595-y. Go to original source... Go to PubMed...
  4. Barth PG. Pontocerebellar hypoplasias. An overview of a group of inherited neurodegenerative disorders with fetal onset. Brain Dev. 1993; 15: 411-422. Go to original source...
  5. Bidichandani SI, Delatycki MB. Friedreich Ataxia Synonym: FRDA, Initial Posting: December 18, 1998; Last Update: July 24, 2014.
  6. Boissé Lomax L, Bayly MA, Hjalgrim H, M?ller RS, Vlaar AM, Aaberg KM, Marquardt I, Gandolfo LC, Willemsen M, Kamsteeg EJ, O'Sullivan JD, Korenke GC, Bloem BR, de Coo IF, Verhagen JMA, Said I, Prescott T, Stray-Pedersen A, Rasmussen M, Vears DF, Lehesjoki AE, Corbett MA, Bahlo M, Gecz J, Dibbens LM, Berkovic SF. 'North Sea' progressive myoclonus epilepsy: phenotype of subjects with GOSR2 mutation. Brain. 2013 Apr; 136(Pt 4): 1146-1154. doi: 10.1093/brain/awt021. Epub 2013 Feb 28 Go to original source... Go to PubMed...
  7. Bushart DD, Murphy GG, Shakkottai VG. Precision medicine in spinocerebellar ataxias: treatment based on common mechanisms of disease. Ann Transl Med. 2016 Jan; 4(2): 25. doi: 10.3978/j.issn.2305-5839.2016.01.06. Review.
  8. Feraco P, Mirabelli-Badenier M, Severino M, Alpigiani MG, Di Rocco M, Biancheri R, Rossi A. The shrunken, bright cerebellum: a characteristic MRI finding in congenital disorders of glycosylation type 1a. AJNR Am J Neuroradiol. 2012; 33: 2062-2067. Go to original source... Go to PubMed...
  9. Joseph JT, Innes AM, Smith AC, Vanstone MR, Schwartzentruber JA, Bulman DE, Majewski J, Daza RA, Hevner RF, Michaud J, Boycott KM; FORGE Canada Consortium. Neuropathologic features of pontocerebellar hypoplasia type 6. J Neuropathol Exp Neurol. 2014; 73(11): 1009-1025. Go to original source... Go to PubMed...
  10. Magner M, Veselá K, Hansíková H, Zeman J, Honzík T. Kazuistika dívky s dědičnou poruchou glykosylace. Pediatr. praxi, 2009; 10(5): 329-330.
  11. Maraş Genç H, Uyur Yalç?n E, Rosti RÖ, Gleeson JG, Kara B. TSEN54 gene-related pontocerebellar hypoplasia type 2 presenting with exaggerated startle response: report of two cases in a family. Turk J Pediatr. 2015 May-Jun; 57(3): 286-289.
  12. Mochida GH, Ganesh VS, de Michelena MI, Dias H, Atabay KD, Kathrein KL, Huang HT, Hill RS, Felie JM, Rakiec D, Gleason D, Hill AD, Malik AN, Barry BJ, Partlow JN, Tan WH, Glader LJ, Barkovich AJ, Dobyns WB, Zon LI, Walsh CA. CHMP1A encodes an essential regulator of BMI1-INK4A in cerebellar development. Nat Genet. 2012; 44: 1260-1264. Go to original source... Go to PubMed...
  13. Namavar Y, Barth PG, Poll-The BT, Baas F. Classification, diagnosis and potential mechanisms in pontocerebellar hypoplasia. Orphanet J Rare Dis. 2011; 6: 50. Go to original source... Go to PubMed...
  14. Patel MS, Becker LE, Toi A, Armstrong DL, Chitayat D. Severe, fetal-onset form of olivopontocerebellar hypoplasia in three sibs: PCH type 5? Am J Med Genet A. 2006; 140: 594-603. Go to original source... Go to PubMed...
  15. Prior TW, Russman BS.Spinal Muscular Atrophy. GeneReviews(R) [Internet] 2000 Feb 24 [Updated 2013 Nov 14].
  16. Richard Gatti, MD Ataxia-Telangiectasia Synonym: Louis-Bar Syndrome Initial Posting: March 19, 1999; Last Update: March 11, 2010.
  17. Rudnik-Schöneborn S, Barth PG, Zerres K. Pontocerebellar hypoplasia. Am J Med Genet C Semin Med Genet. 2014; 166C(2): 173-183. Go to original source... Go to PubMed...




Neurology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.